home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Anti-Cancer Drug Discovery and Development  
  April 29, 2002

Biochemistry / Immunology

 
     
  Strategic Research Institute, Princeton Marriott
06/17/2002 - 06/19/2002


New Oncology Business Development & Licensing Panel:
The Oncology Licensing & Deal-making Climate for 2002-03

Topics Include:
-Cyclin Dependent Kinases
-Tie-2 Kinase
-EGFRs
-Epothilones
-Antimitotic Agents
-Novel Taxanes
-Proteasome Inhibition
-Ubiquitin Ligases
-Vascular Targeting
-Ribozymes
-COX-2 Inhibitors
-Thalidomide
-Telomerase Inhibition
-Antibodies
 
 
Organized by: Strategic Research Institute
Invited Speakers: n/a
 
Deadline for Abstracts: na
 
Registration: n/a
E-mail: ckahan-radhuber@srinstitute.com
 
  Posted by:   Cheryl Kahan-Radhuber  
Host: 12.3.58.3
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2002 HUM-MOLGEN. All rights reserved. Liability and Copyright.